SAMMARTANO, VINCENZO
 Distribuzione geografica
Continente #
EU - Europa 2.001
NA - Nord America 1.713
AS - Asia 1.097
SA - Sud America 198
Continente sconosciuto - Info sul continente non disponibili 108
AF - Africa 59
OC - Oceania 3
Totale 5.179
Nazione #
US - Stati Uniti d'America 1.651
RU - Federazione Russa 584
IT - Italia 517
SG - Singapore 379
CN - Cina 277
IE - Irlanda 217
DE - Germania 183
BR - Brasile 160
GB - Regno Unito 134
FI - Finlandia 123
VN - Vietnam 104
HK - Hong Kong 85
FR - Francia 78
SE - Svezia 60
KR - Corea 56
IN - India 55
BD - Bangladesh 47
CA - Canada 36
ZA - Sudafrica 36
NL - Olanda 25
AR - Argentina 15
MX - Messico 15
PL - Polonia 14
JP - Giappone 13
ES - Italia 12
IQ - Iraq 11
AT - Austria 10
CZ - Repubblica Ceca 10
TR - Turchia 9
PK - Pakistan 8
UA - Ucraina 8
CO - Colombia 6
EC - Ecuador 6
IR - Iran 6
EG - Egitto 5
ID - Indonesia 5
LT - Lituania 5
SA - Arabia Saudita 5
KE - Kenya 4
MY - Malesia 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
AU - Australia 3
BO - Bolivia 3
CH - Svizzera 3
CR - Costa Rica 3
ET - Etiopia 3
MA - Marocco 3
NP - Nepal 3
PY - Paraguay 3
AM - Armenia 2
CI - Costa d'Avorio 2
CL - Cile 2
DO - Repubblica Dominicana 2
HR - Croazia 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
KG - Kirghizistan 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MD - Moldavia 2
NG - Nigeria 2
OM - Oman 2
PH - Filippine 2
TN - Tunisia 2
VE - Venezuela 2
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
DZ - Algeria 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
LU - Lussemburgo 1
MK - Macedonia 1
MN - Mongolia 1
NO - Norvegia 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TL - Timor Orientale 1
UG - Uganda 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.072
Città #
Dallas 283
Singapore 270
Dublin 216
San Jose 167
Moscow 151
Ashburn 146
Munich 135
Santa Clara 114
Milan 103
Hefei 91
Helsinki 85
Council Bluffs 83
Hong Kong 80
Southend 76
Siena 73
Beijing 66
Chandler 58
New York 55
Seoul 54
Los Angeles 51
Fairfield 45
Rome 43
Ho Chi Minh City 37
Florence 36
The Dalles 34
Johannesburg 32
Lauterbourg 31
Woodbridge 24
Turin 23
Turku 23
Seattle 22
São Paulo 22
Hanoi 21
Cambridge 20
Houston 18
Buffalo 17
Princeton 17
Shanghai 17
Columbus 15
Figino 15
Nuremberg 15
Bengaluru 14
Wilmington 14
Lappeenranta 13
Chennai 12
Chicago 12
Warsaw 12
Frankfurt am Main 11
London 11
Montreal 11
Orem 11
Portsmouth 11
Redondo Beach 11
Boston 10
Denver 10
San Francisco 10
Washington 10
Atlanta 9
Messina 9
Mumbai 9
Rio de Janeiro 9
Tokyo 9
Toronto 9
Brooklyn 8
Da Nang 7
Naples 7
Boardman 6
Brno 6
Phoenix 6
Vienna 6
Dearborn 5
Fremont 5
Haiphong 5
Mexico City 5
Miami 5
Modena 5
Querétaro 5
San Diego 5
Stockholm 5
Vancouver 5
Bergamo 4
Dong Ket 4
Manchester 4
Parma 4
Perugia 4
Poplar 4
Porto Alegre 4
San Mateo 4
Secaucus 4
Tashkent 4
Verona 4
Amsterdam 3
Baghdad 3
Biên Hòa 3
Brasília 3
Buscate 3
Cape Town 3
City of London 3
Como 3
Curitiba 3
Totale 3.288
Nome #
Antibody and B-cell responses in myelofibrosis patients after the third doses of mRNA SARS-CoV-2 vaccines 297
Long-Term Safety of Rapid Daratumumab Infusions in Multiple Myeloma Patients 259
Real-world experience with decitabine as a first-line treatment in 306 elderly acute myeloid leukaemia patients unfit for intensive chemotherapy 251
A case of acquired factor XIII deficiency secondary to plasmablastic lymphoma 241
A BRAF Negative Classic Hairy Cell Leukemia Patient in Long Lasting Complete Remission after Rituximab and Pentostatin 236
Efficacy and safety of eltrombopag during conception and first trimester of pregnancy in a case of refractory severe immune thrombocytopenia 226
Antibody response in myelofibrosis patients after three doses of mRNA SARS-CoV-2 vaccine 226
First reported case of secondary mixed phenotype acute leukemia after multiple myeloma 212
Cladribine Efficacy in a Patient with Hairy Cell Leukemia and Severe Renal Insufficiency 204
The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients 201
Real-life experience of edoxaban treatment for venous thromboembolism (VTE)/pulmonary embolism (PE) in patients with isolated positive Lupus Anticoagulant (LAC) during the COVID-19 pandemic lockdown in Italy 198
Therapeutic Vaccinations with p210 Peptides in Imatinib-Treated Chronic Myeloid Leukemia Patients: 10 Years Follow-Up of GIMEMA CML0206 and SI0207 Studies 196
Prognostic value of CD47 overexpression measured by flow cytometry in patients with acute myeloid leukemia 191
Safety of COVID-19 mRNA vaccination in patients with history of acquired hemophilia A: a case series 190
Prospective monitoring of Chronic Myeloid Leukemia Patients from Time of TKI Discontinuation: the fate of Peripheral Blood CD26+ Leukemia Stem Cells 187
Daratumumab in AL Amyloidosis: A Real-Life Experience of the "RTM" (Regional Tuscan Myeloma Network) 185
Functional imaging in the evaluation of treatment response in multiple myeloma: the role of PET-CT and MRI 168
Efficacy and safety of ruxolitinib for Covid-19 related acute respiratory distress syndrome in a patient with blastic plasmacytoid dendritic cell neoplasm (leukemic variant) 168
The slower antibody response in myelofibrosis patients after two doses of MRNA sars-COV-2 vaccine calls for a third dose 166
Pro-Inflammatory and Pro-Oxidative Changes During Nilotinib Treatment in CML Patients: Results of a Prospective Multicenter Front-Line TKIs Study (KIARO Study) 164
Peripheral Blood CD26+ Leukemia Stem Cells Monitoring in Chronic Myeloid Leukemia Patients from Diagnosis to Response to TKIs: Interim Results of a Multicenter Prospective Study (PROSPECTIVE FLOWERS) 162
Anti-BCMA novel therapies for multiple myeloma 152
Prognostic value of CD47 overexpression measured by flow cytometry in acute myeloid leukemia 148
Central nervous system myeloma and unusual extramedullary localizations: real life practical guidance 142
Minimal Residual Disease Significance in Multiple Myeloma Patients Treated with Anti-CD38 Monoclonal Antibodies 136
Therapeutic Management of Patients with FLT3 + Acute Myeloid Leukemia: Case Reports and Focus on Gilteritinib Monotherapy 126
Finding the balance between immunoparesis recovery and multiple myeloma responses after autologous stem cell transplantation in the era of maintenance therapy and novel drugs 111
MRD-negative conversion with daratumumab monotherapy in newly diagnosed multiple myeloma patients in ≥VGPR/MRD-positive after first-line therapy: Final analysis of the open-label, single-arm multicentric phase 2 trial DART4MM 36
Totale 5.179
Categoria #
all - tutte 16.876
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.876


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022127 0 0 10 19 1 5 2 3 5 13 33 36
2022/2023330 13 32 35 33 23 37 24 32 23 6 66 6
2023/2024491 9 14 48 32 30 114 157 16 13 27 4 27
2024/20251.118 34 31 99 54 86 106 96 87 119 50 134 222
2025/20262.627 170 301 265 392 595 102 230 52 65 153 71 231
2026/2027233 109 86 38 0 0 0 0 0 0 0 0 0
Totale 5.179